UBS has recently initiated Myriad Genetics Inc (MYGN) stock to Neutral rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 9, 2024, Leerink Partners had reduced the ...

CGI's sales rose to C$3.79 billion from C$3.60 billion. Analysts expected a rise to C$3.78 billion. Bookings came to C$4.16 billion, down from C$4.19 billion, with a backlog of C$29.77 billion, up ...

The NHS has launched a new genetic blood test to improve the safety of kidney donations from people of Black African and ...

Julie Godin, daughter of Serge Godin, currently serves as co-chair of the Canadian IT and business consulting services firm as well as executive vice president of strategic planning and corporate ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...

CGI (NYSE: GIB) (TSX: GIB.A) today announced the signature of a share purchase agreement on January 29, 2025, to acquire BJSS, a UK-based technology and engineering consultancy known for its ...

CGI said Wednesday that it plans to renew its share repurchase program to buy back up to 10% of its common stock over the course of a one-year period. The Canadian IT company said that its board has ...

This study details the design and optimization of synXVI, a synthetic yeast chromosome, overcoming growth challenges through ...

Mucopolysaccharidosis Type II (MPS II) also known as Hunter Syndrome is when the body lacks the enzyme to break down sugar ...

The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) ("23andMe" or the "Company"), a leading human genetics company ...

When looking at all-cause mortality, rates in patients with Lynch syndrome are comparable with those in the general ...

MONTREAL (AP) — MONTREAL (AP) — CGI Group Inc. (GIB) on Wednesday reported fiscal first-quarter net income of $313.5 million. The Montreal-based company said it had profit of $1.37 per share. Earnings ...